Loading organizations...
§ Private Profile · Lausanne, Vaud, Switzerland
Medical technology company developing nanofluidic point-of-care diagnostic platforms for rapid allergy and sepsis detection from a single blood drop
Based in Epalinges, Switzerland, Abionic is a medical technology company that develops and commercializes nanofluidic point-of-care diagnostic platforms for rapid blood testing. The company's flagship abioSCOPE device utilizes proprietary single-use capsules to deliver lab-quality results for early sepsis detection and personalized allergy profiling to intensive care units, emergency departments, and primary care physicians. Operating with an estimated 50 to 100 employees, the enterprise maintains a manufacturing capacity exceeding one million diagnostic tests annually to supply its healthcare clients. Abionic has secured over CHF 30 million in total venture funding, including a CHF 20 million Series C round, drawing backing from institutional investors such as Pierer Digital and Creathor Venture. The company was founded in 2010 by Nicolas Durand and Iwan Märki as a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL).
Abionic has raised $27.3M across 3 funding rounds.
Abionic has raised $27.3M in total across 3 funding rounds.
Abionic has raised $27.3M across 3 funding rounds. Most recently, it raised $21.0M Series C in March 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 28, 2018 | $21M Series C | Pierangelo Bottinelli | Arkady Volozh, Jean Bernard Dumas, Nelson Dumas, Peter Letmathe, Philippe Glatz, Verve Ventures, Zürcher Kantonalbank | Announced |
| Oct 15, 2014 | $4M Series B | Walid Hanna | Blue Ocean Ventures, Drexel Morgan & CO., NE Holding | Announced |
| Apr 26, 2012 | $2.2M Venture Round | Medholdings | Blue Ocean Ventures, Business Angels Switzerland, Fongit Seed Invest, Polytech Ecosystem Ventures | Announced |
Abionic has raised $27.3M in total across 3 funding rounds.
Abionic's investors include Pierangelo Bottinelli, Arkady Volozh, Jean-Bernard Dumas, Nelson Dumas, Peter Letmathe, Philippe glatz, Verve Ventures, Zürcher Kantonalbank, Walid Hanna, Blue Ocean Ventures, Drexel Morgan & Co., NE Holding.